Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Wegovy (semaglutide 2.4 mg) EPAR Public Assessment Report
Doses change
In the 2023 New England Journal of Medicine Phase 2 obesity trial, participants receiving the highest doses (12 mg weekly) achieved an average body weight reduction of approximately 24% over 48 weeks , alongside structured lifestyle support
doi: 10.3390/healthcare11172443
Three catalysts should have moved the number by then: two-PBM access confirmed by mid-May, Medicare Bridge access starting July 1, and full-scale TV advertising in Q3
For patients with type 2 diabetes, Ozempic on a PBS prescription is the most cost-effective route at approximately $42 per month
)
US$ 21.57
US$ 28.35
US$ 24.30
US$ 28.85
